Gomez, Keith;
Laffan, Mike;
Bradbury, Charlotte;
(2021)
Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials?
British Journal of Haematology
, 192
(3)
pp. 459-466.
10.1111/bjh.17241.
Preview |
Text
Gomez_BJH_Debate on anticoagulation in COVID-19_Full article_01-11-2020.pdf - Accepted Version Download (333kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials? |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1111/bjh.17241 |
| Publisher version: | https://doi.org/10.1111/bjh.17241 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | anticoagulation, clinical trials, coronavirus disease 2019, thromboprophylaxis, venous thrombosis |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Pathology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10160902 |
Downloads since deposit
19Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
